Beta carotene: From biochemistry to clinical trials

Nutrition Reviews

Volumn 58, Issue 2 I, 2000, Pages 39-53

  Pryor, William A ^a   Stahl, Wilhelm ^b   Rock, Cheryl L ^c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASBESTOS; BETA CAROTENE; CAROTENOID; POLYPHENOL; RETINOL; RIBOFLAVIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RISK; CHRONIC DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG RESEARCH; FEMALE; HUMAN; MALE; RISK ASSESSMENT; SMOKING HABIT; VITAMIN SUPPLEMENTATION;

EID: 0034064392     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2000.tb07810.x     Document Type: Article

References (183)

1. Peto R, Doll R, Buckley JD, et al. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201-8
2. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992;18:1-29
3. Hennekens CH, Stampfer MJ, Willett W. Micronutrients and cancer chemoprevention. Cancer Detect Prev 1984;7:147-58
4. Stampfer MJ, Buring JE, Willett W, et al. The 2′2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians. Stat Med 1985;4:111-6
5. Manson JE, Jonas MA, Hunter DJ, et al. Prospective cohort studies of vitamins and cancer. In: Bray GA, Ryan DH, eds. Pennington Center Nutrition Series: vitamins and cancer prevention. Baton Rouge, LA: Louisiana State University Press, 1993; 87-109
6. Greenberg ER. Retinoids or carotenoids: is there another choice? Prev Med 1993;22:723-7
7. Mathews-Roth RM. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases. Ann N Y Acad Sci 1993;691:127-38
8. Mathews-Roth MM. Lack of genotoxicity with beta-carotene. Toxicol Lett 1988;41:185-91
9. Bendich A. The safety of beta carotene. Nutr Cancer 1988;11:207-14
10. Bendich A. Safety issues regarding the use of vitamin supplementation. Ann N Y Acad Sci 1992;669: 300-12
11. Ziegler RG. Carotenoids, cancer, and clinical trials. Ann N Y Acad Sci 1993;691:110-9
12. Heinonen OP, Huttunen JK, Albanes D, et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35
13. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5
14. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334:1145-9
15. Smigel K. Beta carotene fails to prevent cancer in two major studies; CARET intervention stopped. J Natl Cancer Inst 1996;88:145
16. Gaziano JM. Antioxidants in cardiovascular disease: randomized trials. Nutr Rev 1996;54:175-7
17. De Luca LM. Beta-carotene increases lung cancer incidence in cigarette smokers. Nutr Rev 1996;54: 178-80
18. Erdman JW Jr, Russell RM, Mayer J, et al. Beta-carotene and the carotenoids: beyond the intervention trials. Nutr Rev 1996;54:185-8
19. Omenn GS. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health 1998;19:73-99
20. Cooper DA, Eldridge AL, Peters JC. Dietary carotenoids and lung cancer: a review of recent research. Nutr Rev 1999;57:133-45
21. Pryor WA. Letter to editor: beta-carotene, vitamin E, and lung cancer. N Engl J Med 1994;331:612
22. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and ß-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6
23. Boscoboinik D, Szewczyk A, Azzi A. α-Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch Biochem Biophys 1991;286:264-9
24. Azzi A, Boscoboinik D, Marilley D, et al. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 1995;62(suppl): 1337S-46S
25. Azzi A, Boscoboinik D, Clément S, et al. Signaling functions of α-tocopherol in smooth muscle cells. Int J Vitam Nutr Res 1997;67:343-9
26. Mayne ST, Janerich DT, Greenwald P, et al. Dietary beta carotene and lung cancer risk in U.S. non-smokers. J Natl Cancer Inst 1994;86:33-8
27. Krinsky NI. Carotenoids and cancer in animal models. J Nutr 1989;119:123-6
28. Schwartz J, Suda D, Light G. Beta carotene is associated with the regression of hamster buccal pouch carcinoma and the induction of tumor necrosis factor in macrophages. Biochem Biophys Res Commun 1986;136:1130-5
29. Bertram JS, Bortkiewicz H. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr 1995;62(suppl):1327S-36S
30. Katsumura N, Okuno M, Onogi N, et al. Suppression of mouse skin papilloma by canthaxanthin and ß-carotene in vivo. Possibility of the regression of tumorigenesis by carotenoid without conversion to retinoic acid. Nutr Cancer 1996;26:203-8
31. Nishino H. Cancer chemoprevention by natural carotenoids and their related compounds. J Cell Biochem Suppl 1995;22(suppl):231-5
32. Shivapurkar N, Tang Z, Frost A, et al. Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and ß-carotene in rats on a high-risk diet. Cancer Lett 1995;91:125-32
33. Furukawa F, Nishikawa A, Kasahara K, et al. Inhibition of beta-carotene of upper respiratory tumorigenesis in hamsters receiving diethylnitrosamine followed by cigarette smoke exposure. Jpn J Cancer Res 1999;90:154-61
34. Krinsky NI. Actions of carotenoids in biological systems. Annu Rev Nutr 1993;13:561-7
35. International Agency for Research on Cancer (IARC). Some carotenoids: beta carotene, alpha carotene, cryptoxanthins, canthaxanthin, lycopene, lutein and zeaxanthin. IARC handbooks of cancer prevention, vol 2. Lyon, France: International Agency for Research on Cancer, 1998
36. Hennekens CH, Buring JE, Peto R. Antioxidant vitamins - benefits not yet proved. N Engl J Med 1994;330:1080-1
37. van Poppel G. Carotenoids and cancer: an update with emphasis on human intervention studies. Eur J Cancer 1993;29A:1335-44
38. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 1993;49:679-99
39. Flagg EW, Coates RJ, Greenberg RS. Epidemiologic studies of antioxidants and cancer in humans. J Am Coll Nutr 1995;14:419-27
40. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control 1996;7:157-77
41. Kritchevsky SB. ß-Carotene, carotenoids and the prevention of coronary heart disease. J Nutr 1999;129:5-8
42. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76
43. Mills PK, Beeson WL, Phillips RL, et al. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604
44. Key TJA, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer. Br J Cancer 1997;76:678-87
45. Yeum K-J, Ahn S-H, Rupp de Paiva SA, et al. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer. J Nutr 1998; 128:1920-6
46. Chug-Ahuja JK, Holden JM, Forman MR, et al. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc 1993;93:318-23
47. Beecher GR, Khachik F. Evaluation of vitamin A and carotenoid data in food composition tables. J Natl Cancer Inst 1981;73:1397-404
48. Ziegler RG, Colavito EA, Hartge P, et al. Importance of α-carotene, ß-carotene, and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst 1996;88:612-5
49. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996;96: 1027-39
50. Rock CL, Flatt SW, Wright FA, et al. Responsiveness of serum carotenoids to a high-vegetable diet intervention designed to prevent breast cancer recurrence. Cancer Epidemiol Biomarkers Prev 1997;6:617-23
51. Campbell DR, Gross MD, Martini MC, et al. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 1994; 6:493-500
52. Kaugars GE, Silverman S Jr, Lovas JGL, et al. A clinical trial of antioxidant supplements in the treatment of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994;78:462-8
53. Garewal HS, Schantz S. Emerging role of ß-carotene and antioxidant nutrients in prevention of oral cancer. Arch Otolaryngol Head Neck Surg 1995; 121:141-4
54. Stich HF, Mathew B, Sankaranarayanan R, et al. Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of ß-carotene or vitamin A. Am J Clin Nutr 1991;53(suppl):298S-304S
55. van Poppel G, Kok FJ, Hermus RJ. Beta carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer 1992;66: 1164-8
56. van Poppel G, Poulsen H, Loft S, et al. No influence of beta carotene on oxidative DNA damage in male smokers. J Natl Cancer Inst 1995;87:310-1
57. McLarty JW, Holiday DB, Girard WM, et al. Beta-carotene, vitamin A and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995;62(suppl):1431S-8S
58. Zaridze D, Evstifeeva T, Boyle P Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann Epidemiol 1993;3:225-34
59. De Vet HCW, Knipschild PG, Willebrand D, et al. The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 1991;44:273-83
60. Romney SL, Ho GYF, Palan PR, et al. Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 1997;65:483-92
61. Manetta A, Schubbert T, Chapman J, et al. Beta carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiol Biomarkers Prev 1996;5:929-32
62. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta carotene to prevent basal cell and squamous cell cancers of the skin. N Engl J Med 1990;323:789-95
63. Greenberg ER, Baron JA, Tosteson TD, et al. Clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141-7
64. Blot WJ, Li J-Y, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92
65. Albanes D, Heinonen OP, Taylor PR, et al. α-Tocopherol and ß-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70
66. Omenn GS. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 1996;335: 1067-8
67. Bowen PE, Mobarhan S, Smith JC Jr. Carotenoid absorption in humans. Methods Enzymol 1993; 214:3-16
68. Castenmiller JJM, West CE. Bioavailability and bioconversion of carotenoids. Annu Rev Nutr 1998; 18:19-38
69. Wahlquist ML, Wattanapenppaiboon N, Macrae FA, et al. Changes in serum carotenoids in subjects with colorectal adenomas after 24 months of beta carotene supplementation. Am J Clin Nutr 1994; 60:936-43
70. Nierenberg DW, Dain BJ, Mott LA, et al. Effects of 4 y of oral supplementation with ß-carotene on serum concentrations of retinol, tocopherol, and five carotenoids. Am J Clin Nutr 1997;66:315-9
71. Mayne ST, Cartmel B, Silva F, et al. Effect of supplemental ß-carotene on plasma concentrations of carotenoids, retinol, and α-tocopherol in humans. Am J Clin Nutr 1998;68:642-7
72. Albanes D, Virtamo J, Taylor PR, et al. Effects of supplemental ß-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1997;66:366-72
73. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or ß-carotene. Nutr Cancer 1995;24:257-66
74. Sharoni Y, Giron E, Rise M, et al. Effects of lycopene-enriched tomato oleoresin on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Cancer Detect Prev 1997;21:118-23
75. Pastori M, Pfander H, Boscoboinik D, et al. Lycopene in association with α-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 1998;250:582-5
76. Salgo MG, Cueto R, Winston GW, et al. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 1999;26:160-71
77. Wang X-D, Liu C, Bronson RT, et al. Retinoid signaling and activator protein-1 expression in ferrets given ß-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999;91:60-6
78. Pryor WA, Stone K, Zhang L-Y, et al. Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol 1998;11:441-8
79. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997;105:875-82
80. Stone K, Bermúdez E, Pryor WA. Aqueous extracts of cigarette tar containing the tar free radical cause DNA nicks in mammalian cells. Environ Health Perspect 1994;102:173-8
81. Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. In: Diana J, Pryor WA, eds. Tobacco smoking and nutrition: influence of nutrition on tobacco associated health risks. Annals of the New York Academy of Sciences, vol 686. New York: New York Academy of Sciences, 1993;12-28
82. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996;88:1550-9
83. Paetau I, Chen H, Goh NMY, et al. Interactions in the postprandial appearance of beta-carotene and canthaxanthin in plasma triacylglycerol-rich lipoproteins. Am J Clin Nutr 1997;66:1133-43
84. Johnson EJ, Qin J, Krinsky NI, et al. Ingestion by men of a combined dose of beta-carotene and lycopene does not affect the absorption of beta-carotene but improves that of lycopene. J Nutr 1997; 127:1833-7
85. Gärtner C, Stahl W, Sies H. Preferential increase in chylomicron levels of the xanthophylls lutein and zeaxanthin compared to ß-carotene in the human. Int J Vitam Nutr Res 1996;66:119-25
86. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta carotene when administrated to human adults in separate or combined oral doses. Am J Clin Nutr 1995;62:604-10
87. Whyatt RM, Bell DA, Jedrychowski W, et al. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 1998;19:1389-92
88. Stahl W, Sies H. Physical quenching of singlet oxygen and cis-trans isomerization of carotenoids. Ann N Y Acad Sci 1993;691:10-9
89. Mathews-Roth MM. Carotenoids and photoprotection. Photochem Photobiol 1997;65(suppl): 148S-51S
90. Edge R, McGarvey DJ, Truscott TG. The carotenoids as anti-oxidants - a review. J Photochem Photobiol B 1997;41:189-200
91. Palozza P, Krinsky NI. Antioxidant effects of carotenoids in vivo and in vitro: an overview. Methods Enzymol 1992;213:403-20
92. Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr Rev 1998;56:257-65
93. Burton GW, Ingold KU. Autoxidation of biological molecules. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J Am Chem Soc 1981;103:6472-7
94. Pryor WA. Free radicals and lipid peroxidation: what they are and how they got that way. In: Frei B, ed. Natural antioxidants in human health and disease. San Diego, CA: Academic Press, Inc, 1994; 1-24
95. Ingold KU, Webb AC, Witter D, et al. Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch Biochem Biophys 1987;259:224-5
96. Pryor WA, Cornicelli JA, Devall LJ, et al. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J Org Chem 993;58:3521-32
97. Burton GW, Ingold KU. Beta-carotene: an unusual type of lipid antioxidant. Science 1984;224:569-73
98. Palozza P, Moualla S, Krinsky NI. Effects of ß-carotene and α-tocopherol on radical-initiated peroxidation of microsomes. Free Radic Biol Med 1992;13:127-36
99. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-5
100. Kennedy TA, Liebler DC. Peroxyl radical oxidation of ß-carotene: formation of ß-carotene epoxides. Chem Res Toxicol 1991;4:290-5
101. Handelman GJ, van Kuijk FJGM, Chatterjee A, et al. Characterization of products formed during the autoxidation of ß-carotene. Free Radic Biol Med 1991;10:427-37
102. Tsuchiya M, Scita G, Freisleben H, et al. Antioxidant radical-scavenging activity of carotenoids and retinoids compared to α-tocopherol. Methods Enzymol 1992;213:460-72
103. Liebler DC, Kennedy TA. Epoxide products of ß-carotene antioxidant reactions. Methods Enzymol 1992;213:472-9
104. Mortensen A, Skibsted LH. Importance of carotenoid structure in radical-scavenging reactions. J Agric Food Chem 1997;45:2970-7
105. lannone A, Rota C, Bergamini S, et al. Antioxidant activity of carotenoids: an electron-spin resonance study on ß-carotene and lutein interaction with free radicals generated in a chemical system. J Biochem Mol Toxicol 1998;12:299-304
106. Khopde SM, Priyadarsini KI, Mukherjee T, et al. Does ß-carotene protect membrane lipids from nitrogen dioxide? Free Radic Biol Med 1998;25:66-71
107. Yamauchi R, Tsuchihashi K, Kato K. Oxidation products of ß-carotene during the peroxidation of methyl linoleate in the bulk phase. Biosci Biotechnol Biochem 1998;62:1301-6
108. Grolier P, Duszka C, Borel P, et al. In vitro and in vivo inhibition of beta-carotene dioxygenase activity by canthaxanthin in rat intestine. Arch Biochem Biophys 1997;348:233-8
109. Omaye ST, Burri BJ, Senh A, et al. Dietary ß-carotene and carotenoids in young women: effects on plasma ascorbic acid and uric acid. Environmental & Nutritional Interactions 1997;1:273-86
110. Levy Y, Bartha P, Ben-Amotz A, et al. Plasma antioxidants and lipid peroxidation in acute myocardial infarction and thrombolysis. J Am Coll Nutr 1998;17:337-41
111. Lin Y, Burri BJ, Neidinger TR, et al. Estimating the concentration of ß-carotene required for maximal protection of low-density lipoproteins in women. Am J Clin Nutr 1998;67:837-45
112. Ben-Amotz A, Yatziv S, Sela M, et al. Effect of natural ß-carotene supplementation in children exposed to radiation from the Chernobyl accident. Radiat Environ Biophys 1998;37:187-93
113. Palozza P, Luberto C, Calviello G, et al. Antioxidant and prooxidant role of ß-carotene in murine normal and tumor thymocytes: effects of oxygen partial pressure. Free Radic Biol Med 1997;22:1065-73
114. Pryor WA, Strickland T, Church DF. Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous sodium dodecyl sulfate micelle solutions. J Am Chem Soc 1988;110:2224-9
115. Benedetto C, Bocci A, Dianzani MU, et al. Electron spin resonance studies on normal human uterus and cervix and on benign and malignant uterine tumors. Cancer Res 1981;41:2936-42
116. Gerber M, Astre C, Ségala C, et al. Tumor progression and oxidant-antioxidant status. Cancer Lett 1997;114:211-4
117. Swartz HM. Electron spin resonance studies of cancer: experimental results and conceptual implications. In: Armstrong D, Sohol R, Cutler R, et al., eds. Free radicals in molecular biology and aging. New York: Raven Press, 1984;275-93
118. Swartz HM. Electron spin resonance studies of cancer using complex biological systems. In: Floyd RA, ed. Free radicals and cancer. New York: Marcel Dekker, Inc, 1982;81-115
119. Packer L, ed. Methods in enzymology. Carotenoids. Chemistry, separation, quantitation, and antioxidation. San Diego: Academic Press, Inc, 1992;1-535
120. Packer L, ed. Methods in enzymology. Carotenoids. Metabolism, genetics, and biosynthesis. San Diego: Academic Press, Inc, 1996;1-468
121. Sies H, Stahl W. Carotenoids and intercellular communication via gap junctions, Int J Vitam Nutr Res 1997;66:119-25
122. Hughes DA, Wright AJA, Finglas PM, et al. The effect of beta-carotene supplementation on the immune function of blood monocytes from healthy male nonsmokers. J Lab Clin Med 1997;129:309-17
123. Astorg P, Gradelet S, Leclerc J, et al. Effects of provitamin A or non-provitamin A carotenoids on liver xenobiotic-metabolizing enzymes in mice. Nutr Cancer 1997;27:245-9
124. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem 1996;65:475-502
125. Donaldson P, Eckert R, Green C, et al. Gap junction channels: new roles in disease. Histol Histopathol 1997;12:219-31
126. Acevedo P, Bertram JS. Liarozole potentiates the cancer chemopreventive activity of and the up-regulation of gap junctional communication and connexin43 expression by retinoic acid and beta-carotene in 10T1/2 cells. Carcinogenesis 1995;16: 2215-22
127. Yamasaki H. Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. Toxicol Lett 1995;77:55-61
128. Budunova IV, Williams GM. Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol Toxicol 1994;10:71-116
129. Stahl W, Nicolai S, Hanusch M, et al. Vitamin D influences gap junctional communication in C3H/ 10T1/2 murine fibroblast cells. FEBS Lett 1994; 352:1-3
130. Stock A, Sies H, Stahl W. Enhancement of gap junctional communication and connexin43 expression by thyroid hormones. Biochem Pharmacol 1998;55:475-9
131. Hanusch M, Stahl W, Schulz WA, et al. Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin. Arch Biochem Biophys 1995;317:423-8
132. Stahl W, Hanusch M, Sies H. 4-Oxo-retinoic acid is generated from its precursor canthaxanthin and enhances gap junctional communication in 10T1/2 cells. In: Snyder R, ed. Biological reactive intermediates New York: Plenum Press, 1996;121-8
133. Krutovskikh V, Asamoto M, Takasuka N, et al. Differential dose-dependent effects of alpha-, beta-carotenes and lycopene on gap-junctional intercellular communication in rat liver in vivo. Jpn J Cancer Res 1997;88:1121-4
134. Wrighton SA, VandenBranden M, Ring BJ. The human drug metabolizing cytochromes P450. J Pharmacokinet Biopharm 1996;24:461-73
135. Nebert DW, Mckinnon RA, Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 1996;15:273-80
136. Le Marchand L, Franke AA, Custer L, et al. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 1997;7:11-9
137. Astorg P, Gradelet S, Leclerc J, et al. Effects of beta-carotene and canthaxanthin on liver xenobiotic-metabolizing enzymes in the rat. Food Chem Toxicol 1994;32:735-42
138. Gradelet S, Astorg P, Leclerc J, et al. Effects of canthaxanthin, astaxanthin, lycopene and lutein on liver xenobiotic-metabolizing enzymes in the rat. Xenobiotica 1996;26:49-63
139. Gradelet S, Leclerc J, Siess M-H, et al. ß-Apo-8′-carotenal, but not ß-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 1996;26:909-19
140. Paolini M, Cantelli-Forti G, Perocco P, et al. Cocarcinogenic effect of ß-carotene. Nature 1999; 398:760-1
141. Astorg P, Gradelet S, Bergès R, et al. Dietary lycopene decreases the initiation of liver preneoplastic foci by diethylnitrosamine in the rat. Nutr Cancer 1997;29:60-8
142. Wang XD. Absorption and metabolism of beta-carotene. J Am Coll Nutr 1994;13:314-25
143. Olson JA. Absorption, transport, and metabolism of carotenoids in humans. Pure Appl Chem 1994; 66:1011-6
144. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10:940-54
145. Tang G, Krinsky NI. Differentiation between central and excentric cleavage of ß-carotene. Methods Enzymol 1996;214:69-74
146. Krinsky NI, Wang X-D, Tang G, et al. Conversion of carotenoids to retinoids. In: Livrea MA, Packer L, eds. Retinoids: progress in research and clinical applications. New York: Marcel Dekker, Inc, 1993;1-16
147. Zürcher M, Niggli UA, Steck A, et al. Oxidation of carotenoids. Dihydrooxepin derivatives as products of oxidation of canthaxanthin and ß-carotene. Tetrahedron Lett 1997;38:7853-6
148. Handelman GJ, Packer L, Cross CE. Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. Am J Clin Nutr 1996; 63:559-65
149. Van Vliet T, van Schaik F, Schreurs WHP, et al. In vitro measurement of beta-carotene cleavage activity: methodological considerations and the effect of other carotenoids on beta-carotene cleavage. Int J Vitam Nutr Res 1996;66:77-85
150. Stone K, Bermúdez E, Zang L-Y, et al. The ESR properties, DNA nicking and DNA association of aged solutions of catechol versus aqueous extracts of tar from cigarette smoke. Arch Biochem Biophys 1995;319:196-203
151. Zang L-Y, Stone K, Pryor WA. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 1995;19:161-7
152. McClure TD, Liebler DC. A rapid method for profiling the products of antioxidant reactions by negative ion chemical ionization mass spectrometry. Chem Res Toxicol 1995;8:128-35
153. Yeum K-J, Lee-Kim YC, Yoon S, et al. Similar metabolites formed from ß-carotene by human gastric mucosal homogenates, lipoxygenase, or linoleic acid hydroperoxide. Arch Biochem Biophys 1995; 321:167-74
154. Christen WG, Buring JE, Manson JE, et al. Beta-carotene supplementation: a good thing, a bad thing, or nothing? Curr Opin Lipidol 1999;10:29-33
155. Dallongeville J, Marécaux N, Fruchart J-C, et al. Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr 1998;128:1450-7
156. Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 1996:10:690-701
157. Machlin LJ, ed. Vitamin E: a comprehensive treatise. New York: Marcel Dekker, Inc, 1980;1-660
158. Diplock AT, Machlin LJ, Packer L, Pryor WA, eds. Vitamin E: biochemistry and health implications. New York: New York Academy of Sciences, 1989;1-555
159. Lubin B , Machlin LJ, eds. Vitamin E: biochemical, hematological, and clinical aspects. New York: New York Academy of Sciences, 1982;1-506
160. Sauberlich HE, Machlin LJ, eds. Beyond deficiency: new views on the function and health effects of vitamins. New York: New York Academy of Sciences, 1992;1-404
161. Jialal I, Grundy SM. Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 1993;88:2780-6
162. Princen HMG, van Poppel G, Vogelezang C, et al. Supplementation with vitamin E but not ß-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb 1992;12:554-62
163. Verlangieri AJ, Bush MJ. Effects of d-α-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992;11:131-8
164. Carpenter KLH, Cheeseman KH, Van der Veen C, et al. Depletion of alpha-tocopherol in human atherosclerotic lesions. Free Radic Res 1995;23:549-58
165. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906
166. Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med 1993;328:1487-9
167. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9
168. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6
169. Gey KF, Puska P, Jordan P, et al. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53(suppl):326S-34S
170. Stahelin HB, Gey KF, Eicholer M. Plasma antioxidant vitamins and subsequent cancer mortality in 12-year follow-up of the prospective basel study. Am J Epidemiol 1991;133:766-75
171. Riemersma RA, Wood DA, Macintyre CCA, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5
172. Eichholzer M, Stähelin HB, Gey KF, et al. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective basel study. Int J Cancer 1996;66:145-50
173. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 1996;347:781-6
174. Paolisso G, Gambardella A, Giugliano D, et al. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am J Clin Nutr 1995;61:848-52
175. DeMaio SJ, King SB, Lembo NJ, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Nutr 1992;11:68-73
176. Singh RB, Niaz MA, Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital-based case-control study. Journal of Nutritional & Environmental Medicine 1995;5:235-42
177. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992;340:1124-7
178. Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: a randomized controlled trial. JAMA 1997;277:1380-6
179. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000;28:141-64
180. Furukawa F, Nishikawa A, Kasahara K, et al. Inhibition by ß-carotene of upper respiratory tumorigenesis in hamsters receiving diethylnitrosamine followed by cigarette smoke exposure. Jpn J Cancer Res 1999;90:154-61
181. Dugas TR, Morel DW, Harrison EH. Dietary supplementation with ß-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radic Biol Med 1999;26: 1238-44
182. Prakash P, Wang X-D, Pryor WA, et al. The interaction of ß-carotene, ß-apo-carotenals and benzo[a]pyrene in the growth regulation of normal human bronchial epithelial cells. FASEB J 2000, in press
183. Tsubono Y, Tsugane S, Gey KF. Plasma antioxidant vitamins and carotenoids in five Japanese populations with varied mortality from gastric cancer. Nutr Cancer 1999;34:56-61